Catalyst Wire Dossier Catalyst Wire Dossier

Everolimus (Zortress)

everolimus · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Everolimus (Zortress), covering 2014-06-06 to 2014-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients [Phase 3]

See pricing